Navigation Links
Solar vaccine cooler invented by Indian Scientist

The faulty storage of polio vaccines may have been responsible for the resurgence of polio in parts of India. However this situation will soon be resolved// because of the invention of an Indian scientist.

SolarChill, a vaccine cooler has been developed by Rajendra Shende under the United Nations Environment Programme (UNEP). This solar vaccine cooler is expected to be of much use especially in rural parts where electricity is in short supply.

The vaccine cooler promises to be a viable eco-friendly solution that will replaces the lead batteries and chlorofluorocarbons responsible for ozone depletion and used in conventional refrigerators.

Shende based in Paris is the head of UNEP's Ozone Action Branch and has come to Delhi to deliver two units of SolarChill to its first Indian customer -- President A P J Abdul Kalam, who has proposed to install them in the clinic at Rashtrapati Bhavan complex.

Shende said, 'SolarChill does not use lead batteries or kerosene used in conventional solar chillers. Instead, we use the sun's energy to create a thick layer of ice which helps in maintaining temperature in the cooler between minus two degrees and eight degrees Celsius.'

Shende was struck with this idea during his travels in Burkina Faso in 2000. He said, 'I thought that if we could develop a vaccine cooler that uses the solar energy so abundant in Burkina Faso and other developing countries, it would be a boon for vaccination programmes implemented there.'


'"/>




Page: 1

Related medicine news :

1. Solarium use is associated with an increased risk of skin cancer
2. The Science of Solar Eclipse
3. Link Between Solar Flares And Strokes Under Study
4. Changes in Solar Brightness Too Weak to Explain Global Warming
5. China Introduces Solar-powered Baths
6. New hope for cancer victims – will vaccine cure the deadly bug
7. New vaccine helps allergy and asthma patients
8. Man against HIV – new vaccine ready for human trials
9. New vaccine helps allergy and asthma patients
10. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
11. HIV did not arise from polio vaccine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... , ... April 25, 2017 , ... Back Pain ... and back pain with a reputable physician in their area, announces the launch of ... patient information for patients who are looking for reputable physicians to help them with ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality ... problems, I focus on preventative care with all my patients to alleviate possible future issues. ... feel free to contact my office and my trained staff will assist you in any ...
(Date:4/25/2017)... ... ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley Bobrow will be featured ... publish in summer 2017. , Dr. Bobrow, MD, FACEP, FAHA, is an Emergency ... He also serves as Medical Director for the Bureau of Emergency Medical Services and ...
(Date:4/25/2017)... ... , ... Vetoquinol USA® , a world-class developer of ... the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin ... , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and ...
(Date:4/24/2017)... Massachusetts (PRWEB) , ... April 24, 2017 , ... ... will help busy nursing professionals advance their careers. Beginning in the fall of 2017, ... Nursing (BSN) degree in as few as 16 months and for as little as ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 ... stimulate an immune response in pets such as ... products are of various types such as Attenuated ... Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated ... as virus or bacteria, which have been weakend ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
(Date:4/18/2017)... , April 18, 2017  Cardinal Health (NYSE: ... fiscal 2017 earnings per share (EPS) guidance and ... This is in conjunction with this morning,s announcement of ... Thrombosis and Nutritional Insufficiency businesses. Cardinal Health ... operations will be at the bottom of its previous ...
Breaking Medicine Technology: